A Mixed-Model Approach for Powerful Testing of Genetic Associations with Cancer Risk Incorporating Tumor Characteristics
preprint
OA: closed
Abstract
A bstract Cancers are routinely classified into subtypes according to various features, including histopathological characteristics and molecular markers. Previous genome-wide association studies have reported heterogeneous associations between loci and cancer subtypes. However, it is not evident what is the optimal modeling strategy for handling correlated tumor features, missing data, and increased degrees-of-freedom in the underlying tests of associations. We propose to test for genetic associations using a mixed-effect two-stage polytomous model score test (MTOP). In the first stage, a standard polytomous model is used to specify all possible sub-types defined by the cross-classification of the tumor characteristics. In the second stage, the subtype-specific case-control odds ratios are specified using a more parsimonious model based on the case-control odds ratio for a baseline subtype, and the case-case parameters associated with tumor markers. Further, to reduce the degrees-of-freedom, we specify case-case parameters for additional exploratory markers using a random-effect model. We use the Expectation-Maximization (EM) algorithm to account for missing data on tumor markers. Through simulations across a range of realistic scenarios and data from the Polish Breast Cancer Study (PBCS), we show MTOP outperforms alternative methods for identifying heterogeneous associations between risk loci and tumor subtypes. The proposed methods have been implemented in a user-friendly and high-speed R statistical package called TOP ( https://github.com/andrewhaoyu/TOP ).
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (25)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes via crossref
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses via crossref
- doi:10.1038/nature13385 via crossref
- doi:10.1198/016214504000000124 via crossref
- doi:10.2307/2346911 via crossref
- doi:10.1111/j.2517-6161.1977.tb01600.x via crossref
- doi:10.1093/oxfordjournals.aje.a114338 via crossref
- doi:10.1038/sj.bjc.6603207 via crossref
- doi:10.1038/ng.2561 via crossref
- doi:10.2307/2286276 via crossref
- doi:10.1093/biomet/84.2.309 via crossref
- doi:10.1111/j.2517-6161.1982.tb01203.x via crossref
- doi:10.1038/nature24284 via crossref
- doi:10.1038/ng.3785 via crossref
- doi:10.1038/nature11412 via crossref
- doi:10.1038/35021093 via crossref
- doi:10.1016/j.breast.2015.07.008 via crossref
- doi:10.1093/aje/kws457 via crossref
- doi:10.1002/gepi.21717 via crossref
- doi:10.1093/aje/kwv040 via crossref
- doi:10.1016/j.ajhg.2011.05.029 via crossref
- doi:10.1158/1055-9965.epi-06-0806 via crossref
- doi:10.1002/sim.7405 via crossref
- doi:10.1093/biostatistics/4.1.57 via crossref
- doi:10.1016/j.bbcan.2015.06.002 via crossref
Source provenance
- crossref
- last seen: 2026-05-24T01:00:07.465974+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-11T06:40:09.570059+00:00